You can test for chlamydia as early as one week after exposure, and testing at two weeks catches nearly all infections. If you test sooner than seven days, there’s a meaningful chance the infection hasn’t produced enough bacteria for the test to detect, giving you a false negative.
The Testing Window Explained
After chlamydia enters your body, the bacteria need time to multiply before a test can pick them up. At one week post-exposure, most infections are detectable. By two weeks, the test catches almost all of them. This means if you had a specific sexual encounter you’re concerned about, the sweet spot for a reliable result is 7 to 14 days afterward.
Testing in the first few days after exposure is unreliable. The bacterial load is simply too low for even the most sensitive tests to consistently detect. If you do test early and get a negative result, you should test again at the two-week mark to be confident.
Why Waiting Matters for Accuracy
The standard test for chlamydia is a nucleic acid amplification test, which works by detecting genetic material from the bacteria. It’s highly sensitive: in men, it picks up infections 89% to 100% of the time. In women, sensitivity ranges from 72% to 100% depending on the sample type and study. But that sensitivity depends on enough bacteria being present to amplify. Test too early, and you get a clean result that doesn’t reflect reality.
A false negative isn’t just misleading for you. It can lead to unknowingly passing the infection to a partner or allowing it to progress without treatment, which in women can eventually cause pelvic inflammatory disease and fertility problems.
Swabs vs. Urine Samples
How your sample is collected affects accuracy more than most people realize. For women, vaginal swabs are significantly more sensitive than urine tests. A meta-analysis in the Annals of Family Medicine found vaginal swabs detected chlamydia about 94% of the time, while urine caught only 87% of infections. That gap means urine testing may miss up to 10% more infections in women compared to vaginal swabs.
The reason is straightforward: chlamydia in women typically lives in the cervix and vaginal canal, not the urethra. Urine only picks up the infection if cervical or vaginal material happens to wash into it at the start of urination. For men, urine testing performs well because the infection is located in the urethra, which urine passes through directly. If you’re a woman and have the option, a vaginal swab gives you the most reliable result. Many clinics now offer self-collected vaginal swabs, which are just as accurate as clinician-collected ones.
Don’t Wait for Symptoms
Chlamydia is often completely silent. The majority of women and a large proportion of men with chlamydia have no symptoms at all. When symptoms do appear, they typically show up one to three weeks after infection, but many people never develop noticeable signs. This means you cannot use the absence of symptoms to rule out infection. If you’ve had unprotected sex with a new partner, or a partner has tested positive, testing on a timeline is more reliable than waiting to see if something feels off.
Retesting After Treatment
If you’ve been treated for chlamydia, there are two important timelines to know. First, don’t retest too soon after finishing antibiotics. Testing within four weeks of completing treatment can produce a false positive because the test detects genetic material from dead bacteria that your body hasn’t cleared yet. This doesn’t mean you’re still infected; it means the test is picking up leftovers.
For most people, a routine “test of cure” right after treatment isn’t necessary as long as you took the full course of antibiotics. The exception is pregnancy: pregnant women should have a test of cure 3 to 4 weeks after treatment, since detecting treatment failure or reinfection early matters more during pregnancy. Testing before three weeks risks a false positive, while waiting longer than four weeks could delay catching a new infection.
Regardless of pregnancy status, everyone treated for chlamydia should retest at about three months. This isn’t to check whether the antibiotics worked. It’s to catch reinfection, which is common, especially if your sexual partner wasn’t treated at the same time. Scheduling that three-month follow-up at the same visit where you receive treatment makes it easier to remember.
Routine Screening if You’re at Risk
Beyond testing after a known exposure, regular screening matters for people with ongoing risk factors. The U.S. Preventive Services Task Force recommends screening sexually active women under 25 annually, along with older women who have new or multiple partners. There’s no fixed screening interval backed by clinical trials. Instead, the guidance is practical: if your sexual history includes new or persistent risk factors since your last negative test, it’s time to screen again.